Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;7(6):R1189-99.
doi: 10.1186/ar1804. Epub 2005 Aug 17.

The contact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis

Affiliations

The contact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis

Manuela Rossol et al. Arthritis Res Ther. 2005.

Abstract

Stimulation of monocytes/macrophages after cell contact with preactivated T cells has been suggested to contribute to the excessive TNF-alpha production in rheumatoid arthritis (RA). In this study, T cell-contact-dependent TNF-alpha production by peripheral-blood monocytes in vitro was investigated and found to be significantly lower in treated and untreated patients with RA than in healthy controls. This suppression was not due to a general deficiency of monocytes to respond, because responses to lipopolysaccharide were comparable in patients and controls. In agreement with the pivotal role of TNF-alpha in RA, T cell-dependent induction of TNF-alpha in synovial macrophages was fivefold to tenfold higher than in peripheral-blood monocytes from either patients or controls. The decreased response of peripheral-blood monocytes from patients with RA was found to be mediated by inhibitory serum factors, because the addition of patient sera to monocytes from healthy controls suppressed TNF-alpha response in the co-culture assay. Preincubation of monocytes from healthy controls with RA serum was sufficient to suppress the subsequent TNF-alpha response in T cell co-cultures, indicating that inhibitory factors do indeed bind to monocyte surfaces, which might represent a regulatory counter-action of the immune system to the long-standing and consuming autoimmune process in RA. There are some indications that apolipoprotein A-1 might be part of this regulatory system.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T cell induced production of TNF-α by monocytes from healthy donors. (a) Fixed stimulated T cells induce tumour necrosis factor (TNF)-α production by monocytes in a dose-dependent manner. Peripheral-blood T cells (106/ml) were cultured for 48 hours in the presence of immobilized anti-CD3 (3.3 μg/ml) and soluble anti-CD28 (0.8 μg/ml) antibodies. Stimulated T cells were fixed and incubated for 24 hours with freshly isolated monocytes (1.5 × 106/ml) at the indicated ratios. Values are means ± SEM from four different experiments. (b) Cell–cell contact is necessary for T cell-induced production of TNF-α in monocytes. Peripheral-blood T cells (106/ml) were cultured for 48 hours in the presence or absence of immobilized anti-CD3 (3.3 μg/ml) and soluble anti-CD28 (0.8 μg/ml) antibodies. Stimulated (sTc) and resting (rTc) T cells were fixed and incubated for 24 hours with freshly isolated monocytes (1.5 × 106/ml) at a ratio of 7:1 in a transwell system as described in the Materials and methods section. T cells and monocytes were physically separated by the semi-permeable membrane (with insert) or had direct cell–cell contact (without insert). Lipopolysaccharide (LPS; 100 ng/ml) was used as a positive control. Values are means ± SEM for experiments with three different donors. (c) T cell-induced TNF-α production by monocytes is time-dependent. Peripheral-blood T cells (106/ml) were cultured for 48 hours in the presence or absence of immobilized anti-CD3 (3.3 μg/ml) and soluble anti-CD28 (0.8 μg/ml) antibodies. Stimulated (sTc) and resting (rTc) T cells were fixed and incubated for the indicated durations with freshly isolated monocytes (1.5 × 106/ml) at a ratio of 7:1. Values are means ± SEM for experiments with three different donors. Levels of significance: * P < 0.05, *** P < 0.001.
Figure 2
Figure 2
Decreased T cell induced production of TNF-α in monocytes from RA patients. (a) T cell-induced tumour necrosis factor (TNF)-α secretion by monocytes from patients with rheumatoid arthritis (RA) is decreased in comparison with those from healthy controls. Peripheral-blood T cells (106/ml) were cultured for 48 hours in the presence or absence of immobilized anti-CD3 (3.3 μg/ml) and soluble anti-CD28 (0.8 μg/ml) antibodies. Stimulated (sTc) and resting (rTc) T cells were fixed and incubated with freshly isolated monocytes (1.5 × 106/ml) at a ratio of 7:1. After 24 hours, the concentration of TNF-α was measured in the supernatant. Lipopolysaccharide (LPS; 100 ng/dl) was used as a positive control. Data are means ± SEM of values from 20 patients with RA and 20 age-matched controls. (b) Macrophages separated from the synovial membrane of patients with RA produce large amounts of TNF-α after contact with preactivated T cells. Stimulated (sTc) and resting (rTc) T cells were fixed and incubated with freshly isolated synovial macrophages from patients with RA (1.5 × 106/ml) at a ratio of 7:1. After 24 hours, the concentration of TNF-α was measured in the supernatant. LPS (100 ng/ml) was used as a positive control. Data are means ± SEM of values from six independent experiments. Level of significance: not significant. (c) Decrease in T cell-induced TNF-α secretion by monocytes from patients with RA is independent of previous and current treatments. The graph depicts the T cell-induced TNF-α production by monocytes of patients with RA either receiving methotrexate (MTX; n = 5) or not receiving immunosuppressive treatment (untreated; n = 6). For comparison, results for six age-matched controls are given (P < 0.05, significant difference compared with untreated patients).
Figure 3
Figure 3
Sera from RA patients inhibit T cell-induced TNF-α production by monocytes from healthy donors. (a) Peripheral-blood T cells (106/ml) were cultured for 48 hours in the presence of immobilized anti-CD3 (3.3 μg/ml) and soluble anti-CD28 (0.8 μg/ml) antibodies. The cells were fixed and incubated for 24 hours with freshly isolated monocytes (1.5 × 106/ml) at a ratio of 7:1. The co-incubation assay was performed in the presence of 10% FCS, 10% serum from patients (serum [RA]) or from healthy donors (serum [control]). All data are expressed as percentages of TNF-α produced in the 10% FCS containing co-culture system (100%). Data are means ± SEM for 10 independent experiments; levels of significance are as indicated. (b) Monocytes from healthy donors were preincubated with 50% control sera (nine donors) or RA sera (six sera from patients with RA, which were previously found to inhibit T cell-dependent monocyte activation) and then washed thoroughly three times. Co-culture experiments were performed as described in the text in medium supplemented with 10% FCS. All data are expressed as percentages of TNF-α produced in the co-culture system containing 10% FCS. Data are means ± SEM for four independent experiments; levels of significance are as indicated.
Figure 4
Figure 4
Inhibition of T cell-induced TNF-α production by monocytes is specific for active RA. (a) Preactivated peripheral-blood T cells (106/ml; see Materials and methods) were fixed and incubated for 24 hours with freshly isolated peripheral-blood monocytes (1.5 × 106/ml) at a ratio of 7:1. The co-incubation assay was performed in the presence of 10% FCS, 10% serum from healthy donors (serum [control], n = 10), from patients with active RA (serum [aRA], n = 20) or from patients with non-active RA (serum [nRA], n = 20). All data are expressed as percentages of TNF-α produced in the co-culture system containing 10% FCS. Data are means ± SEM; levels of significance are as indicated. (b) Co-incubation assays (see (a)) were performed in the presence of 10% FCS, 10% serum from healthy donors (serum [control], n = 10)), serum from patients with psoriatic arthritis (serum [PsA], n = 9) or from patients with ankylosing spondylitis (serum [aSp], n = 9). All data are expressed as percentages of TNF-α produced in the co-culture system containing 10% FCS. Data are means ± SEM; levels of significance are as indicated.
Figure 5
Figure 5
Inhibitory activity of rheumatoid arthritis (RA) sera is not heat stable. Six sera from patients with RA, which previously were found to strongly inhibit T cell-dependent monocyte activation were incubated at 56°C for 30 min, at 70°C for 10 min or at 95°C for 2 min. Co-culture experiments were performed in the presence of 10% FCS or 10% RA sera. All data are expressed as percentages of tumour necrosis factor-α produced in the co-culture system containing 10% FCS. Data are means ± SEM from six independent experiments. P = 0.002 (significant difference from the 100% values).
Figure 6
Figure 6
ApoA-1 concentrations are decreased in non-active RA but correlate with the inhibitory serum activity in active RA. (a) Box plot depicting ApoA-1 concentrations in sera from healthy controls (n = 20), in patients with active RA (n = 20) and in patients with non-active disease (n = 20). Levels of significance are given; n.s., not significant. (b) Scatter plot depicting the correlation between ApoA-1 concentrations and inhibitory serum activity in sera from patients with active RA. Each data point represents the ApoA-1 concentration in relation to the inhibitory activity. Tumour necrosis factor (TNF)-α production in the co-culture system containing 10% FCS is set to 100%. The regression line illustrates the negative correlation between the two parameters (correlation coefficient R = -0.527; P = 0.016).

References

    1. Burger D. Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction. Eur Cytokine Netw. 2000;11:346–353. - PubMed
    1. Isler P, Vey E, Zhang JH, Dayer JM. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw. 1993;4:15–23. - PubMed
    1. Manie S, Kubar J, Limouse M, Ferrua B, Ticchioni M, Breittmayer JP, Peyron JF, Schaffar L, Rossi B. CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen. Eur Cytokine Netw. 1993;4:7–13. - PubMed
    1. Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 1995;3:119–125. doi: 10.1016/1074-7613(95)90164-7. - DOI - PubMed
    1. Armant M, Rubio M, Delespesse G, Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J Immunol. 1995;155:4868–4875. - PubMed

Publication types

MeSH terms

Substances